Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

01521 Frontage Holdings Corporation

2.100
+0.010+0.48%
Closed 10/05 16:08 CCT
High
2.170
Open
2.170
Turnover
4.30M
Low
2.100
Pre Close
2.090
Volume
2.02M
Market Cap
4.36B
P/E(TTM)
24.71
52wk High
5.260
Shares
2.08B
P/E(Static)
30.43
52wk Low
1.980
Float Cap
4.36B
Bid/Ask %
-3.93%
Historical High
9.180
Shs Float
2.08B
Volume Ratio
0.85
Historical Low
1.980
Dividend TTM
--
Div Yield TTM
--
P/B
1.71
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.10%
Amplitude
3.35%
Avg Price
2.134
Lot Size
2000
Float Cap
4.36B
Bid/Ask %
-3.93%
Historical High
9.180
Shs Float
2.08B
Volume Ratio
0.85
Historical Low
1.980
Dividend TTM
--
P/B
1.71
Dividend LFY
--
Turnover Ratio
0.10%
Amplitude
3.35%
Avg Price
2.134
Lot Size
2000
Price Forecast

No Data

News

Comment

Company Overview More
Fangda Holdings is a holding company. The company is a contract research organization (CRO) that provides pharmaceutical companies with integrated, science-driven research, analysis and development services throughout the drug discovery and development process. Its business divisions include North America and the people's Republic of China (PRC). The North American division includes laboratory testing, chemistry, manufacturing and control (CMC), preclinical research and chemical services in the United States and Canada. The China division includes laboratory testing, CMC, preclinical research, bioequivalent clinical and chemical services in China. The company's preclinical research services include drug metabolism and pharmacokinetics (DMPK) services as well as safety and toxicology services, absorption, fragmentation, metabolism and excretion, and compound screening services. The company's services and solutions include candidate drug evaluation, product development and testing services.
CEO: Song Li
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...